Development
Gilead Sciences, Inc.
GILD
$112.46
-$2.05-1.79%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 5.67B | 5.88B | 5.48B | 5.58B | 4.59B |
| Total Depreciation and Amortization | 2.69B | 2.53B | 2.37B | 2.22B | 2.10B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.95B | 1.64B | 1.87B | 2.32B | 4.14B |
| Change in Net Operating Assets | -2.30B | -1.64B | -211.00M | -1.14B | -1.76B |
| Cash from Operations | 8.01B | 8.40B | 9.51B | 8.98B | 9.07B |
| Capital Expenditure | -585.00M | -551.00M | -586.00M | -590.00M | -728.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.15B | -1.09B | -1.46B | -1.54B | -1.80B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -528.00M | -271.00M | -351.00M | -91.00M | 59.00M |
| Cash from Investing | -2.27B | -1.91B | -2.40B | -2.22B | -2.47B |
| Total Debt Issued | 1.98B | 1.98B | -- | -- | -- |
| Total Debt Repaid | -2.25B | -2.25B | -1.00B | -1.00B | -1.50B |
| Issuance of Common Stock | 232.00M | 382.00M | 335.00M | 312.00M | 309.00M |
| Repurchase of Common Stock | -1.00B | -1.64B | -1.52B | -1.44B | -1.40B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.81B | -3.78B | -3.76B | -3.73B | -3.71B |
| Other Financing Activities | -278.00M | -268.00M | -235.00M | -216.00M | -173.00M |
| Cash from Financing | -5.13B | -5.58B | -6.18B | -6.08B | -6.47B |
| Foreign Exchange rate Adjustments | 57.00M | 95.00M | 29.00M | -32.00M | -63.00M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -1.00M | -- |
| Net Change in Cash | 673.00M | 1.01B | 965.00M | 640.00M | 74.00M |